A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
The present study sought to determine whether social phobics, like patients with panic disorder, have increased sensitivity to the panicogenic effects of pentagastrin. Intravenous pentagastrin and placebo were administered in a double-blind fashion to 19 social phobics, 11 patients with panic disorder, and 19 healthy controls while they participated in a structured social interaction task. Behavioral, cardiovascular, and neuroendocrine responses were obtained. Pentagastrin led to panic attacks in 47% of the social phobics, 64% of the panic disorder patients, and 11% of the healthy controls. The social interaction itself increased anxiety, blood pressure, and pulse in all three groups. These findings suggest that the panicogenic effects of pentagastrin are not limited to patients with panic disorder and provide further evidence for shared neurobiology in social phobia and panic disorder.
McCann
U D
UD
Unit on Anxiety Disorders, Biological Psychiatry Branch, NIMH, NIH, Bethesda, MD 20892-1272, USA.
Slate
S O
SO
Geraci
M
M
Roscow-Terrill
D
D
Uhde
T W
TW
D000293:Adolescent; D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D016584:Panic Disorder / Q000139:chemically induced*; D010418:Pentagastrin / Q000009:adverse effects*; D010698:Phobic Disorders / Q000150:complications*; D011569:Psychiatric Status Rating Scales
D010418:Pentagastrin